SlimShot has two different public presentations that need to be reconciled before paying. Its main website describes medical weight management without naming a GLP-1 medicine or price. A separate order page on wlmeds.slimshot.net lists semaglutide at $269 per month and a tirzepatide subscription at $297 per month. The offer page is accessible, but that does not verify that every displayed option is currently fulfilled. [Source]
The practical issue is identifying the actual business, clinician, prescription and agreement behind the selected offer. This review compares public pages checked October 15, 2026. We did not submit an intake, place an order, independently credential a clinician or inspect a pharmacy.
What the two pages establish
The main site identifies NOVA HEALTH PEPTIDES LLC ARIEL GUTIERREZ SOLE MBR and describes physician-guided consultations, metabolic assessment, nutrition and lifestyle support, and follow-up. It says telehealth may be available for eligible visits. It does not provide a named medicine, program price or state-by-state availability list in the reviewed homepage. The operator name alone does not identify a prescribing physician. [Source]
The separate order page renders two subscription items: semaglutide at $269 monthly and tirzepatide, misspelled in the item label, at $297 monthly. Its marketing says medication is included and shipped to the patient. We did not verify a completed quote, eligibility, taxes, renewal amount or any additional care charge. Its initial order total is not a reliable final bill before the form is completed. [Source]
There is also a product-description mismatch: the second offer repeats a semaglutide supply description beneath the $297 price while discussing tirzepatide, including an oral formulation. That prevents a confident conclusion about the exact product or route included in that subscription. Ask for the prescribed ingredient, formulation and route in writing rather than resolving the inconsistency from the headline alone. [Source]
The linked agreement names another operator
The terms PDF linked from the order page is dated November 22, 2023 and identifies WL Meds LLC, with references to WLMeds and VestraMeds. The main site instead identifies the Nova Health Peptides entity. The order page also uses a different phone number and an Arizona mailing address. These observations do not establish whether the entities are affiliated or whether the older agreement governs a new purchase. Obtain that answer before treating the documents as one confirmed current contract. [Source]
The order page names Vios Compounding Pharmacy in Michigan. The older linked agreement lists Potter’s House Apothecary, Empower and Olympia, allows other pharmacies, and permits transfers among participating pharmacies. Neither a footer address nor a historical network list identifies the pharmacy that would dispense a particular prescription today. [Source]
The PDF describes third-party medical groups and providers, prescription approval after consultation, and cash-pay services. It does not establish the individual prescriber or current state availability for this specific funnel. A broad country selector on an order form is not evidence that clinical care or prescription shipping is authorized in every country listed. [Source]
Read renewal and cancellation terms with their date attached
The linked 2023 agreement describes automatic renewals. The first renewal may be early without a specified maximum in that clause; later charges and shipments may move up by two days. It requires cancellation at least two days before the applicable renewal processing date, with cancellation effective at the end of the current period. Those are the older linked document’s terms, not a verified promise about a newly selected plan. [Source]
The same document provides cancellation by the listed support contact, phone or online account. It excludes refunds for partly used subscription periods except at the company’s discretion, and says billing resumes after a pause unless canceled. It does not supply a clear current SlimShot-specific refund calculation for an assessment denial or a prescription not yet shipped. [Source]
The main-site terms say individual products or services specify their own refund policies. That generic statement does not resolve the older order-page agreement, a selected subscription’s processing date or who receives a cancellation request. Save the final agreement and ask which entity charges the card, when renewal processes and what happens if a clinician does not prescribe. [Source]
Product claims are not a substitute for product identity
The order page presents testimonials and weight-loss claims but does not establish a measured SlimShot patient cohort in the reviewed material. Its oral tirzepatide language also does not demonstrate absorption or clinical equivalence to an injection. We did not identify a product-specific comparative study on that page. [Source]
FDA explains that compounded GLP-1 drugs are not FDA-approved and do not undergo its premarket review for safety, effectiveness and quality. A pharmacy name or an ingredient shared with an approved medicine does not remove that distinction. [Source]
Use the pharmacy verification guide to connect the proposed prescription to an identifiable dispensing pharmacy. The Unique Physique review illustrates a different issue: explicit service policies that add detail to a simple monthly-price advertisement. For SlimShot, resolving the operator and product inconsistencies is the first useful step.
Sources and limits
New provider sources checked October 15, 2026. Earlier material retains its original source history. Federal sources provide general guidance; provider pages describe advertised terms. These sources do not assess an individual patient's situation.
- SlimShot: Current medical weight-management homepageProvider public information; checked October 15, 2026
- SlimShot: Separate public WL Meds order pageProvider public information; checked October 15, 2026
- SlimShot: Main-site terms of serviceProvider public information; checked October 15, 2026
- WL Meds: Terms linked from the SlimShot order page; November 22, 2023 PDFProvider public information; checked October 15, 2026
- FDA — concerns with unapproved GLP-1 drugsRegulator guidance